Retrieve available abstracts of 306 articles: HTML format
Single Articles
June 2025
CAO S, Cao C, Wang S Efficacy and prognosis of allogeneic hematopoietic stem cell transplantation in
aggressive NK-cell leukemia: a meta-analysis.
Ann Hematol. 2025 Jun 5. doi: 10.1007/s00277-025-06423. PubMedAbstract available
May 2025
SUN K, Shi ZY, Wang YZ, Xie DH, et al The expression patterns and prognostic significance of PD-1 and TIM-3 on T cells
and the differentiated subsets in acute myeloid leukemia.
Ann Hematol. 2025 May 27. doi: 10.1007/s00277-025-06418. PubMedAbstract available
TRAN QUANG V, Cretin J, Loyaux R, Ben Jedidia B, et al Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and
chronic myeloid leukemia.
Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06417. PubMedAbstract available
FIANCHI L, Piciocchi A, Guolo F, Marchesi F, et al Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid
Leukemia between the registrative trial and a real-life study.
Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06381. PubMedAbstract available
PARK S, Kim HK Epidemiologic sequential analysis of pure red blood cell aplasia and T-cell large
granular lymphocyte leukemia in Korea.
Ann Hematol. 2025 May 22. doi: 10.1007/s00277-025-06406. PubMedAbstract available
LIN J, Liu X, Ying S, Zhu Y, et al Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia
with myelodysplasia-related gene mutations under low-intensity therapy.
Ann Hematol. 2025 May 22. doi: 10.1007/s00277-025-06399. PubMedAbstract available
GRIMALDI F, Memoli M, Avilia S, Russo R, et al Molecular analysis of T-cell Acute Lymphoblastic Leukemia arising after Essential
Thrombocythemia foreshadows a distinct clonal route for lymphoid blast crisis in
Philadelphia-negative chronic myeloproliferative neoplasm: a case report with
literary r
Ann Hematol. 2025 May 22. doi: 10.1007/s00277-025-06404. PubMedAbstract available
ZHU T, Wang L, Jiang H, Huang S, et al Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly
diagnosed and relapsed/refractory acute myeloid leukemia: results of a single
center study.
Ann Hematol. 2025 May 20. doi: 10.1007/s00277-025-06389. PubMedAbstract available
LEWANDOWSKI K, Janicki M, Baranska M, Kandula Z, et al Inotuzumab therapy resulted in molecular remission of relapsed/resistant B-cell
acute lymphoblastic leukemia with BCR::ABL1 Lys404Glu mutation.
Ann Hematol. 2025 May 16. doi: 10.1007/s00277-025-06385. PubMedAbstract available
CECCHI N, Sciume M, Ricchiuti A, Bosi A, et al Rituximab efficacy for minimal residual disease eradication in
philadelphia-negative acute lymphoblastic leukemia CD20.
Ann Hematol. 2025 May 16. doi: 10.1007/s00277-025-06332. PubMedAbstract available
SAMMARTANO V, Sicuranza A, Pacelli P, Bestoso E, et al Prognostic value of CD47 overexpression measured by flow cytometry in acute
myeloid leukemia.
Ann Hematol. 2025 May 15. doi: 10.1007/s00277-025-06401. PubMedAbstract available
AVAL OS, Ahmadi A, Hemid Al-Athari AJ, Soleimani Samarkhazan H, et al "Galectin-9: A double-edged sword in Acute Myeloid Leukemia".
Ann Hematol. 2025 May 9. doi: 10.1007/s00277-025-06387. PubMedAbstract available
YOKOYAMA H, Fuji S, Murata M, Hirayama M, et al Impact of graft-versus-host disease on outcomes of cord blood transplantation
according to HLA disparity and its prophylaxis type.
Ann Hematol. 2025;104:2905-2913. PubMedAbstract available
TURKINA A, Vinogradova O, Lomaia E, Shatokhina E, et al Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine
kinase-inhibitor, in chronic myeloid leukaemia.
Ann Hematol. 2025;104:2707-2715. PubMedAbstract available
LIU J, Guo D, Lian H, Ding P, et al Combination of pre-transplant flow cytometry, WT1 expression, and NGS for MRD
monitoring is potent in predicting the prognosis of AML receiving allogeneic
transplantation.
Ann Hematol. 2025;104:2915-2926. PubMedAbstract available
MIAO L, Wang X, Yao M, Tao Y, et al Clinicopathological and prognostic significance of DDX41 mutation in myeloid
neoplasms: a systematic review and meta-analysis.
Ann Hematol. 2025;104:2581-2591. PubMedAbstract available
AN N, Bian K, Li C Alemtuzumab for haematological malignancies.
Ann Hematol. 2025;104:2593-2603. PubMedAbstract available
STUCKEY R, Navarrete Bullon L, Borrero Borrego A, Vidal Ballester V, et al Molecular response with asciminib 20 mg QD in a patient intolerant to multiple
TKIs.
Ann Hematol. 2025;104:3007-3009. PubMedAbstract available
YANG X, Duan Y, Zhou C, Zhang N, et al A case series of B-Lymphoblastic lymphoma with C-MYC rearrangement in children:
diagnostic and therapeutic challenges.
Ann Hematol. 2025;104:3059-3066. PubMedAbstract available
GARCIA M, Croizier C, Lazarian G, Quinquenel A, et al Multiplex digital PCR enables sensitive detection of resistance to BTK
inhibitors.
Ann Hematol. 2025;104:2889-2895. PubMedAbstract available
April 2025
STOCK CN, Chillon CJ, Hernandez CL, Moro FM, et al Combination of disease burden before allogeneic transplantation and early
post-transplant minimal residual disease predicts survival in patients with acute
myeloid leukemia.
Ann Hematol. 2025 Apr 25. doi: 10.1007/s00277-025-06325. PubMedAbstract available
MAHADEVIA H, Ponvilawan B, Shrestha A Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic
lymphocytic leukemia: a systematic review and meta-analysis of clinical trials.
Ann Hematol. 2025 Apr 24. doi: 10.1007/s00277-025-06373. PubMedAbstract available
LIU X, Chai X, Yu Q, Wang W, et al Clinical features and outcomes in large granular lymphocyte leukemia - associated
pure red cell aplasia with STAT3 mutation.
Ann Hematol. 2025 Apr 23. doi: 10.1007/s00277-025-06371. PubMedAbstract available
WANG Y, Liu Q, Xu CL, Huang DP, et al Blinatumomab in combination with olverembatinib and concurrent intrathecal
chemotherapy successfully treated a chronic myeloid leukemia relapse with central
nervous system blast crisis: case report and literature review.
Ann Hematol. 2025 Apr 9. doi: 10.1007/s00277-025-06351. PubMedAbstract available
ZHOU Y, Zhang H, Zheng X, Zhang R, et al Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell
transplantation in acute myeloid leukemia patients.
Ann Hematol. 2025 Apr 9. doi: 10.1007/s00277-025-06346. PubMedAbstract available
PATRA PC, Rainchwar S, Singh R, Bhatia N, et al Allogeneic transplantation for CML blast phase: Learnings over last decade from a
single centre in North India.
Ann Hematol. 2025;104:2483-2493. PubMedAbstract available
FUJI S, Tokunaga M, Utsunomiya A, Makiyama J, et al Improving outcome prediction in indolent ATL by subdividing intermediate risk
into low- and high-intermediate groups.
Ann Hematol. 2025;104:2429-2436. PubMedAbstract available
March 2025
AN R, Bao W, Yan Z, Sun H, et al Therapy related acute myeloid leukemia secondary to CAR-T therapy in
refractory/relapsed multiple myeloma patient showing poor prognosis.
Ann Hematol. 2025 Mar 31. doi: 10.1007/s00277-025-06310. PubMedAbstract available
JAMIL A, Aslam S, Riaz R, Qureshi Z, et al Comparative efficacy of venetoclax-based regiments in the management of chronic
lymphocytic leukemia: a systematic review and metanalysis.
Ann Hematol. 2025 Mar 29. doi: 10.1007/s00277-025-06280. PubMedAbstract available
YANG K, Yang B, Zhou Y, Huang Q, et al Promising activity of Selinexor in the treatment of a patient with refractory
NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia.
Ann Hematol. 2025 Mar 18. doi: 10.1007/s00277-025-06312. PubMedAbstract available
MIRAZIMI Y, Aghayan AH, Atashi A, Mohammadi D, et al Prognostic value of circular RNAs expression and their correlation with
clinicopathological features in acute myeloid leukemia: a systematic review and
meta-analysis.
Ann Hematol. 2025 Mar 15. doi: 10.1007/s00277-025-06300. PubMedAbstract available
ZHANG L, Lu Y, Jiang J, Wu G, et al Case report: single-cell transcriptome sequencing reveals the clonal origin of
mature plasmacytoid dendritic cell proliferation in early T-cell precursor
lymphoblastic leukemia.
Ann Hematol. 2025 Mar 14. doi: 10.1007/s00277-025-06301. PubMedAbstract available
JIANG B, Li J, Liu L, Du X, et al Gilteritinib versus salvage chemotherapy in predominantly Asian patients with
relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of
COMMODORE in China, South-East Asia, and Russia.
Ann Hematol. 2025 Mar 10. doi: 10.1007/s00277-025-06235. PubMedAbstract available
GUTIERREZ DE MORAES PEREIRA GB, Rocha VA, Barbosa PVR, Cralcev C, et al Twin pregnancy during treatment with asciminib for chronic myeloid leukemia - a
case report.
Ann Hematol. 2025 Mar 8. doi: 10.1007/s00277-025-06238. PubMedAbstract available
SONG BQ, Kong X, Liu Y, Pu Y, et al Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger
adults with newly diagnosed AML.
Ann Hematol. 2025;104:1617-1622. PubMedAbstract available
NIYONIZEYE E, Wang X, Yan D, Richard SA, et al Building a new score system for the diagnosis and differential diagnosis of
typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry
immunophenotyping.
Ann Hematol. 2025;104:1807-1819. PubMedAbstract available
PAN H, Gao Z, Lian Y, Zhao J, et al Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory
AML: a prospective cohort study.
Ann Hematol. 2025;104:1597-1604. PubMedAbstract available
MENG M, Feng X, Zhang Y, Gao Y, et al Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine
in T-cell lymphoblastic lymphoma.
Ann Hematol. 2025;104:1747-1756. PubMedAbstract available
MOUSAVI S, Nouri S, Sadeghipour A, Atashi A, et al Tumor microenvironment as a novel therapeutic target for lymphoid leukemias.
Ann Hematol. 2025;104:1367-1386. PubMedAbstract available
LEE BJ Venetoclax and hypomethylating agents versus tagraxofusp in older patients with
blastic plasmacytoid dendritic cell neoplasm.
Ann Hematol. 2025;104:2069-2071. PubMedAbstract available
HUANG G, Cai X, Li D Significance of targeting DNMT3A mutations in AML.
Ann Hematol. 2025;104:1399-1414. PubMedAbstract available
February 2025
HORNAK T, Zackova D, Mayer J Total psoriasis regression in a patient with chronic myeloid leukemia treated
using nilotinib.
Ann Hematol. 2025 Feb 28. doi: 10.1007/s00277-025-06228. PubMedAbstract available
FANG Y, Zhao M, Luo T, Cui J, et al Prediction of survival in acute myeloid leukemia patients by extracellular to
intracellular water ratio and sarcopenia: development and validation of a novel
nomogram.
Ann Hematol. 2025 Feb 18. doi: 10.1007/s00277-025-06248. PubMedAbstract available
HAO L, Yao Y, Yang L Thromboembolism in adult patients with acute promyelocytic leukemia: clinical
characteristics, risk factors, and a predictive nomogram.
Ann Hematol. 2025 Feb 18. doi: 10.1007/s00277-025-06251. PubMedAbstract available
IBERTI M, Loschi M, Keslair F, Deckert M, et al Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling
evidence on the role of IL3 overexpression in tumorigenesis.
Ann Hematol. 2025 Feb 9. doi: 10.1007/s00277-025-06217. PubMedAbstract available
IYAMA S, Chi S, Idogawa M, Ikezoe T, et al Prognostic impact of TET2 mutations in patients with acute myeloid leukemia:
HM-SCREEN-Japan 01 and 02 study.
Ann Hematol. 2025 Feb 8. doi: 10.1007/s00277-025-06227. PubMedAbstract available
SHUMILOV E, Mazzeo P, Trautmann M, Levien L, et al Functional apoptosis profiling reveals vulnerabilities in T-cell large granular
lymphocytic leukemia.
Ann Hematol. 2025 Feb 6. doi: 10.1007/s00277-025-06230. PubMedAbstract available
SHAFIEIZADEGAN S, Aberuyi N, Rahgozar S The molecular impact of miR-326 in acute lymphoblastic leukemia and its cross
talk with P53.
Ann Hematol. 2025 Feb 5. doi: 10.1007/s00277-024-06181. PubMedAbstract available
CULLOT G, Lagarde V, Cayuela JM, Prouzet-Mauleon V, et al Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a
Ph + ALL patient.
Ann Hematol. 2025;104:1117-1126. PubMedAbstract available
LIN L, Yang KH, Chen CC, Shen SH, et al Risk factors and a prediction model of severe asparaginase-associated
pancreatitis in children.
Ann Hematol. 2025;104:1015-1022. PubMedAbstract available
SOLANA-ALTABELLA A, Rodriguez-Veiga R, Martinez-Cuadron D, Montesinos P, et al A systematic review of venetoclax for the treatment of unfit AML patients in
real-world: is all that glitters gold?
Ann Hematol. 2025;104:913-935. PubMedAbstract available
January 2025
YIGIT KAYA S, Vatani M, Akil R, Cakir T, et al A complete response with daratumumab, venetoclax, azacitidine and dexamethasone
in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic
leukemia/lymphoma patient.
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06118. PubMedAbstract available
ZHENG J, Zhou Y, Zhao Y, Luo Y, et al Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia
undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase
inhibitors: development and validation of a clinical prediction model based on
cytogene
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-025-06202. PubMedAbstract available
HIDALGO-GOMEZ G, Tazon-Vega B, Palacio C, Saumell S, et al How to combine multiple tools for the genetic diagnosis work-up of pediatric
B-cell acute lymphoblastic leukemia.
Ann Hematol. 2025 Jan 23. doi: 10.1007/s00277-024-06151. PubMedAbstract available
MASUDA Y, Sadato D, Toya T, Hirama C, et al Telomere shortening in donor cell-derived acute promyelocytic leukemia after
allogeneic hematopoietic stem cell transplantation: a case report.
Ann Hematol. 2025 Jan 22. doi: 10.1007/s00277-025-06222. PubMedAbstract available
YE Y, Zhao Z, Mo W, Liu W, et al Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia
patient and its implications for clinical treatment.
Ann Hematol. 2025 Jan 21. doi: 10.1007/s00277-024-06169. PubMedAbstract available
SOSSA-MELO C, Abello-Polo V, Salazar LA, Pena AM, et al Characteristics, outcomes and treatment patterns in acute myeloid leukemia
patients 60 years or older in Colombia: a RENEHOC-PETHEMA study.
Ann Hematol. 2025 Jan 16. doi: 10.1007/s00277-024-06120. PubMedAbstract available
KONG J, Zheng FM, Yan CH, Wang JZ, et al Efficacy and safety of olverembatinib as maintenance therapy after allogeneic
hematopoietic cell transplantation in Philadelphia chromosome-positive acute
lymphoblastic leukemia.
Ann Hematol. 2025 Jan 16. doi: 10.1007/s00277-025-06198. PubMedAbstract available
SCHULZ F, Roggenbuck C, Kundgen A, Kasprzak A, et al Outcomes in patients with acute myeloid leukemia older than 70 years within the
last 30 years, a single center experience.
Ann Hematol. 2025 Jan 11. doi: 10.1007/s00277-025-06196. PubMedAbstract available
SHAKEEL L, Khaliq N, Shaukat A, Khan A, et al The efficacy and safety of nelarabine in relapsed or refractory T-cell acute
lymphoblastic leukemia: a systematic review and meta-analysis.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-024-06121. PubMedAbstract available
YOUSEFI A, Levin MD, Cornelissen JJ, Westerweel PE, et al Sustained treatment-free remission in two chronic myeloid leukemia patients after
asciminib discontinuation: a report of two cases.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-024-06170. PubMedAbstract available
JIMBO K, Ishigaki T, Sakashita M, Andoh S, et al Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous
system infiltration and utility of CD7 versus CADM1 flowcytometric plots of
cerebrospinal fluid.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-025-06186. PubMedAbstract available
YU S, Yang S, Hu L, Duan W, et al Genetic abnormalities predict outcomes in patients with core binding factor acute
myeloid leukemia.
Ann Hematol. 2025 Jan 10. doi: 10.1007/s00277-024-06182. PubMedAbstract available
JIN S, Chang M, Feng L, Hao Y, et al PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction
chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia.
Ann Hematol. 2025 Jan 8. doi: 10.1007/s00277-025-06183. PubMedAbstract available
BUZZATTI E, Botti C, Presicci R, Mauro C, et al A fatal case of peritonitis due to colonic localization of acute myeloid
leukemia.
Ann Hematol. 2025 Jan 7. doi: 10.1007/s00277-024-06172. PubMedAbstract available
OH YE, Min GJ, Jeon YW, Kim TY, et al Long-term clinical outcome of a weekly 2-chlorodeoxyadenosine regimen in
treatment-naive patients with hairy cell leukemia.
Ann Hematol. 2025 Jan 4. doi: 10.1007/s00277-024-06173. PubMedAbstract available
MAFFEI R, Paolini A, Conte B, Riva G, et al Distribution of different classes of CSF3R mutations and co-mutational pattern in
360 myeloid neoplasia.
Ann Hematol. 2025;104:263-274. PubMedAbstract available
HUANG N, Song Y, Wu L, He Q, et al Validation and improvement of the molecular international prognostic scoring
system in Chinese patients with myelodysplastic syndromes.
Ann Hematol. 2025;104:193-206. PubMedAbstract available
HOSOBA R, Fukuhara S, Kogure Y, Takano K, et al Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with
eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion gene.
Ann Hematol. 2025;104:809-813. PubMedAbstract available
HULS G, Chitu DA, Tick L, Boersma R, et al Midostaurin added to 10-day decitabine, for patients unfit for intensive
chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational
status, does not improve outcome.
Ann Hematol. 2025;104:361-368. PubMedAbstract available
GIELIS S, Flumens D, van der Heijden S, Versteven M, et al Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients
uncovers higher diversity in patients in remission than in relapsed.
Ann Hematol. 2025;104:317-333. PubMedAbstract available
December 2024
LIU Q, Zhao J, Li Y, Jia Y, et al Comparative safety of different first-line treatments for chronic lymphocytic
leukemia/small lymphocytic lymphoma: A systematic review and network
meta-analysis.
Ann Hematol. 2024 Dec 28. doi: 10.1007/s00277-024-06136. PubMedAbstract available
ZHAO Y, Yu X, Yan L, Shi D, et al Study on clinical features of early death in older patients with acute
promyelocytic leukemia.
Ann Hematol. 2024 Dec 27. doi: 10.1007/s00277-024-06165. PubMedAbstract available
SUGIHARA A, Kubota Y, Nagaie T, Fujita M, et al Epstein-Barr virus-associated lymphoproliferative disease during remission after
induction therapy with dasatinib in Philadelphia chromosome-positive acute
lymphoblastic leukemia: a case report.
Ann Hematol. 2024 Dec 21. doi: 10.1007/s00277-024-06153. PubMedAbstract available
MA JF, Yan CL, Jia X, Zhu HJ, et al Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute
lymphoblastic leukemia/lymphoma.
Ann Hematol. 2024 Dec 18. doi: 10.1007/s00277-024-06132. PubMedAbstract available
TANG X, Liu S, Hu Y, Chen F, et al Clearing MRD positivity with blinatumomab in pediatric B-cell acute lymphoblastic
leukemia: insights from droplet digital PCR and flow cytometry.
Ann Hematol. 2024 Dec 13. doi: 10.1007/s00277-024-06126. PubMedAbstract available
LI W, Ma R, Fan X, Xiao Z, et al M1 macrophage-derived exosomes alleviate leukemia by causing mitochondrial
dysfunction.
Ann Hematol. 2024 Dec 12. doi: 10.1007/s00277-024-06138. PubMedAbstract available
SANCHEZ-MENDOZA SE, de Deus-Wagatsuma VM, do Nascimento MC, Lima K, et al All-trans retinoic acid potentiates cell death induced by quizartinib in acute
myeloid leukemia with FLT3-ITD mutations.
Ann Hematol. 2024 Dec 11. doi: 10.1007/s00277-024-06089. PubMedAbstract available
CHANSWANGPHUWANA C, Sukswai N, Tangnuntachai N, Rojnuckarin P, et al Survival impact of hypoxia-inducible factor-1 alpha (HIF-1alpha) in Nucleophosmin1
mutated acute myeloid leukemia.
Ann Hematol. 2024 Dec 4. doi: 10.1007/s00277-024-06124. PubMedAbstract available
MATSUKAWA T, Onozawa M, Kondo T, Kanaya M, et al FLT3 inhibitors and hematopoietic cell transplantation prolong survival in
patients with FLT3-ITD-positive AML.
Ann Hematol. 2024;103:5333-5340. PubMedAbstract available
TAUVERON-JALENQUES U, Sarr K, Guieze R, Giordano C, et al Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of
menin-KMT2A inhibitor therapy for acute myeloid leukaemia.
Ann Hematol. 2024;103:5985-5988. PubMedAbstract available
BIN T, Tang J, Lu B, Xu XJ, et al Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on
golgi- associated genes.
Ann Hematol. 2024;103:5297-5314. PubMedAbstract available
KOUIDRI K, Acker F, Toenges R, Pfaff S, et al Central nervous system relapse after allogeneic HCT in FLT3-mutated AML.
Ann Hematol. 2024;103:5387-5393. PubMedAbstract available
CUI K, Zhang S, Wang Q, Wei Y, et al Prognostic significance of early nk cell recovery in pediatric t-cell replete
allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2024;103:5769-5780. PubMedAbstract available
PUZO CJ, Hager KM, Rinder HM, Weinberg OK, et al Overall survival in TP53-mutated AML and MDS.
Ann Hematol. 2024;103:5359-5369. PubMedAbstract available
LEE BJ, Griffin SP, Doh J, Ciurea SO, et al Intensification of upfront chemotherapy for patients with myeloid blast phase
CML: a single center experience.
Ann Hematol. 2024;103:5395-5403. PubMedAbstract available
SUN Y, Wang Q, Zhang Z, Wang Q, et al Distinct clinical profiles and patient outcomes in aCML and CNL.
Ann Hematol. 2024;103:5325-5332. PubMedAbstract available
HAN X, Liu W, Kang Z, Li D, et al Prognostic significance of GATA2 in patients with MDS/AML: a systematic review
and meta-analysis.
Ann Hematol. 2024;103:4943-4952. PubMedAbstract available
JAFARI PA, Bagheri R, Lavasani S, Goudarzi S, et al DNMT3A-R882: a mutation with many paradoxes.
Ann Hematol. 2024;103:4981-4988. PubMedAbstract available
November 2024
BERNARDI S, Cavalleri A, Mutti S, Garuffo L, et al Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular
response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE
study.
Ann Hematol. 2024 Nov 29. doi: 10.1007/s00277-024-06100. PubMedAbstract available
LI J, Chen J, Wang Q, Ou J, et al Clonal evolution defines risk stratification for central nervous system leukemia
in adult acute lymphoblastic leukemia.
Ann Hematol. 2024 Nov 29. doi: 10.1007/s00277-024-06116. PubMedAbstract available
ZHA C, Yang X, Yang J, Zhang Y, et al Immunosuppressive microenvironment in acute myeloid leukemia: overview,
therapeutic targets and corresponding strategies.
Ann Hematol. 2024 Nov 28. doi: 10.1007/s00277-024-06117. PubMedAbstract available
LI Y, Zhang Q, Shao H Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia.
Ann Hematol. 2024 Nov 27. doi: 10.1007/s00277-024-06114. PubMedAbstract available
ABDELFATTAH NE, Elsayed GM, Soliman AH, Ebeid EN, et al Copy number alterations in pediatric B-cell precursor acute lymphoblastic
leukemia patients and their association with patients' outcome.
Ann Hematol. 2024 Nov 26. doi: 10.1007/s00277-024-06102. PubMedAbstract available
MA H, Du Y, Li J, Rao J, et al Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or
unfit patients with newly diagnosed acute myeloid leukemia: a multicenter,
prospective study.
Ann Hematol. 2024 Nov 26. doi: 10.1007/s00277-024-06097. PubMedAbstract available
HE Y, Ding J, Liu L, Chen J, et al Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway
in chronic myeloid leukemia.
Ann Hematol. 2024 Nov 25. doi: 10.1007/s00277-024-06099. PubMedAbstract available
CHEN X, Ma X, Yuan L, Wang F, et al The second adult case of NUTM1 fusion-positive B-cell lymphoblastic leukemia: A
recurring pattern of poor prognosis.
Ann Hematol. 2024 Nov 25. doi: 10.1007/s00277-024-06115. PubMedAbstract available
FLEISCHMANN M, Jentzsch M, Brioli A, Eisele F, et al Correction to: Azacitidine in combination with shortened venetoclax treatment
cycles in patients with acute myeloid leukemia.
Ann Hematol. 2024 Nov 20. doi: 10.1007/s00277-024-06095. PubMed
BLANKSTEIN AR, Choi N, Mozessohn L, Sanford D, et al Supportive care strategies in myelodysplastic syndromes and acute myeloid
leukemia in older adults: a national survey of Canadian hematologists.
Ann Hematol. 2024 Nov 20. doi: 10.1007/s00277-024-06085. PubMedAbstract available
MIZUNO S, Hosoi H, Takami A, Kawata T, et al Reappraising the prognostic relevance of cytogenetic risk in patients with acute
myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol. 2024 Nov 19. doi: 10.1007/s00277-024-06094. PubMedAbstract available
AU WY, Chow C, To KF, Ma ESK, et al Mixed-phenotype leukemia with TCF3::ZNF384 fusion presenting as an isolated
mediastinal mass.
Ann Hematol. 2024 Nov 12. doi: 10.1007/s00277-024-06042. PubMedAbstract available
TOLOZA MJ, Lincango M, Camacho MF, Ledesma MM, et al Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal
differential expression dynamics on imatinib response in chronic myeloid
leukemia.
Ann Hematol. 2024 Nov 7. doi: 10.1007/s00277-024-06074. PubMedAbstract available
MONSEREENUSORN C, Techavichit P, Sathitsamitphong L, Lertvivatpong N, et al Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace
diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology
Group.
Ann Hematol. 2024 Nov 5. doi: 10.1007/s00277-024-06068. PubMedAbstract available
HUANG N, Chang C, Wu L, He Q, et al Distinct mutation features and its clinical significance in myelodysplastic
syndromes with normal karyotype.
Ann Hematol. 2024;103:4485-4495. PubMedAbstract available
SPATH C, Neumann T, Kruger WH Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after
allogeneic stem cell transplantation - a case report.
Ann Hematol. 2024;103:4777-4778. PubMedAbstract available
October 2024
ZHENG S, Tong Y, Yang L, Chen J, et al The prognostic significance of genetics in acute myeloid leukemia under
venetoclax-based treatment.
Ann Hematol. 2024 Oct 29. doi: 10.1007/s00277-024-06050. PubMedAbstract available
FORGHIERI F, Bettelli F, Sgromo S, Nadali G, et al Management of latent tuberculosis infection (LTBI) in adult patients with newly
diagnosed acute leukemia: results of a survey among Italian centers belonging to
SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Ann Hematol. 2024 Oct 28. doi: 10.1007/s00277-024-06047. PubMed
MCCLELLAN K, Messina J, Saullo J, Huggins J, et al Incidence of infection in patients with acute myeloid leukemia receiving
high-dose cytarabine consolidation.
Ann Hematol. 2024 Oct 27. doi: 10.1007/s00277-024-06069. PubMedAbstract available
FLEISCHMANN M, Jentzsch M, Brioli A, Eisele F, et al Azacitidine in combination with shortened venetoclax treatment cycles in patients
with acute myeloid leukemia.
Ann Hematol. 2024 Oct 25. doi: 10.1007/s00277-024-06048. PubMedAbstract available
EFFICACE F, Sparano F, Breccia M, Greco C, et al Health-related quality of life benefits of arsenic trioxide in patients with
non-high-risk acute promyelocytic leukemia are sustained over time: long-term
results of the GIMEMA APL0406 trial.
Ann Hematol. 2024 Oct 23. doi: 10.1007/s00277-024-06038. PubMedAbstract available
LI S, Gao R, Han X, Wang K, et al MALAT1/miR-582-5p/GALNT1/MUC1 axis modulates progression of AML leukemia stem
cells by regulating JAK2/STAT3 pathway.
Ann Hematol. 2024 Oct 21. doi: 10.1007/s00277-024-06043. PubMedAbstract available
TRIPATHI S, K V VB, Nayak AR, Chauhan R, et al Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic
myeloid leukemia - an uncommon presentation: a case report and literature review
in the post imatinib era.
Ann Hematol. 2024 Oct 16. doi: 10.1007/s00277-024-06044. PubMedAbstract available
SCALZULLI E, Costa A, Carmosino I, Musiu P, et al Different prognosis according to treatment in patients with acute promyelocytic
leukemia: How the outcome changed over time.
Ann Hematol. 2024 Oct 15. doi: 10.1007/s00277-024-06014. PubMedAbstract available
ZHU Y, Huang J, Wang Y, Han Y, et al Olverembatinib treatment in adult patients with newly diagnosed Philadelphia
chromosome-positive acute lymphoblastic leukemia.
Ann Hematol. 2024 Oct 14. doi: 10.1007/s00277-024-06027. PubMedAbstract available
YANG L, Ma D, Liu S, Zou L, et al The DHODH inhibitor teriflunomide impedes cell proliferation and enhances
chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia.
Ann Hematol. 2024 Oct 8. doi: 10.1007/s00277-024-05998. PubMedAbstract available
WERY AR, Salaroli A, Andreozzi F, Paesmans M, et al Measurable residual disease assessment prior to allogeneic hematopoietic stem
cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a
20-year monocentric study.
Ann Hematol. 2024 Oct 4. doi: 10.1007/s00277-024-06017. PubMedAbstract available
LI HD, Chen SS, Ding J, Zhang CL, et al Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD
mutations.
Ann Hematol. 2024;103:4295-4304. PubMedAbstract available
CHEN CY Chromothripsis in myeloid malignancies.
Ann Hematol. 2024;103:3955-3962. PubMedAbstract available
GAO Y, Xi Y, Chen W, Meng Y, et al Early predictor for differentiation syndrome in newly diagnosed acute
promyelocytic leukaemia patients treated with single-agent arsenic trioxide.
Ann Hematol. 2024;103:3947-3954. PubMedAbstract available
GE S, Wang J, He Q, Zhu J, et al Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of
clinical choice for AML.
Ann Hematol. 2024;103:3855-3866. PubMedAbstract available
September 2024
PAN YS, Li H, Yang M, Zhang CL, et al A case of visual impairment due to HHV-6 encephalitis after allogeneic
hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2
subtype.
Ann Hematol. 2024 Sep 30. doi: 10.1007/s00277-024-06030. PubMedAbstract available
AHMAD F, Shah A, Angi M, Narmawala Q, et al Identification of a novel cryptic variant chromosomal rearrangement involving
9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid
leukemia: a case report.
Ann Hematol. 2024 Sep 27. doi: 10.1007/s00277-024-05966. PubMedAbstract available
HAGIHARA M, Yasu T, Gando Y, Sugi T, et al Increased trough concentration of venetoclax when combined with itraconazole for
acute myeloid leukemia.
Ann Hematol. 2024 Sep 27. doi: 10.1007/s00277-024-05845. PubMedAbstract available
KRAMP LJ, Heydrich-Karsten C, Sembill S, Karow A, et al CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly
relapsed lymphoid blast phase.
Ann Hematol. 2024 Sep 21. doi: 10.1007/s00277-024-06011. PubMedAbstract available
DUAN W, Jia J, Wang J, Liu X, et al Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid
leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or
a < 3log reduction of MRD2 predicted poor survival.
Ann Hematol. 2024 Sep 17. doi: 10.1007/s00277-024-06001. PubMedAbstract available
ZHAO Z, Lan J Detection methods and prognosis implications of measurable residual disease in
acute myeloid leukemia.
Ann Hematol. 2024 Sep 16. doi: 10.1007/s00277-024-06008. PubMedAbstract available
YANG S, Huang H, Zhou K, Zhao X, et al Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic
leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial.
Ann Hematol. 2024 Sep 14. doi: 10.1007/s00277-024-05978. PubMedAbstract available
PEREZ-LAMAS L, Diaz AS, Castera EM, Soto MH, et al Outcomes of chronic myeloid leukemia patients after therapeutic failure to
conventional tyrosine kinase inhibitors and asciminib.
Ann Hematol. 2024 Sep 13. doi: 10.1007/s00277-024-05906. PubMedAbstract available
ATNAF A, Akelew Y, Abebaw D, Muche Y, et al The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic
biomarkers of acute myeloid leukemia.
Ann Hematol. 2024 Sep 12. doi: 10.1007/s00277-024-05987. PubMedAbstract available
HAN P, Wei S, Wang H, Cai Y, et al Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in
acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade.
Ann Hematol. 2024 Sep 12. doi: 10.1007/s00277-024-06003. PubMedAbstract available
SIFFEL C, Richter J, Anderson-Smits C, Kamieniak M, et al Treatment patterns and burden of infection in patients with chronic lymphocytic
leukemia and secondary immunodeficiency: a retrospective database study.
Ann Hematol. 2024 Sep 12. doi: 10.1007/s00277-024-05984. PubMedAbstract available
JAIN AG, Volpe VO, Wang C, Ball S, et al Outcomes by best response with hypomethylating agent plus venetoclax in adults
with previously untreated acute myeloid leukemia.
Ann Hematol. 2024 Sep 7. doi: 10.1007/s00277-024-05976. PubMedAbstract available
WEI Y, Qian K, Le N, Wang L, et al Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide
conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia:
the phase 2 prospective study.
Ann Hematol. 2024 Sep 7. doi: 10.1007/s00277-024-05972. PubMedAbstract available
STEINER N, Baier K, Ritter D, Rudzki J, et al Early autologous and/or allogeneic stem cell transplantation for adult patients
with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A
retrospective single-centre analysis.
Ann Hematol. 2024 Sep 3. doi: 10.1007/s00277-024-05979. PubMedAbstract available
TALEBI E, Ghoraeian P, Shams Z, Rahimi H, et al Molecular insights into the hedgehog signaling pathway correlated non-coding RNAs
in acute lymphoblastic leukemia, a bioinformatics study.
Ann Hematol. 2024 Sep 3. doi: 10.1007/s00277-024-05763. PubMedAbstract available
SOBAS M, Ianotto JC, Kiladjian JJ, Harrison C, et al Myeloproliferative neoplasms: young patients, current data and future
considerations.
Ann Hematol. 2024;103:3287-3291. PubMedAbstract available
GUARNERA L, Tiravanti I, Guiducci A, Coppola L, et al Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case
control study.
Ann Hematol. 2024;103:3831-3833. PubMed
HUA W, Qi J, Zhou M, Han S, et al Overexpression of REC8 induces aberrant gamete meiotic division and contributes
to AML pathogenesis - a multiplexed microarray analysis and mendelian
randomization study.
Ann Hematol. 2024;103:3563-3572. PubMedAbstract available
COX ER, Summers C, Milano F, Dahlberg A, et al Outcomes of patients undergoing third hematopoietic cell transplantation for
hematologic malignancies.
Ann Hematol. 2024;103:3737-3743. PubMedAbstract available
CHEN F ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine
kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate.
Ann Hematol. 2024;103:3801-3804. PubMedAbstract available
ROZENTAL A, Halperin E, Leibovitch C, Barzili M, et al CML in the very elderly: the impact of comorbidities and TKI selection in a
real-life multicenter study.
Ann Hematol. 2024;103:3585-3594. PubMedAbstract available
HU L, Li Z, Yang S, Zhao T, et al Allogeneic stem cell transplantation is still a highly curative therapy in adults
with philadelphia chromosome-positive acute lymphoblastic leukaemia.
Ann Hematol. 2024;103:3745-3754. PubMedAbstract available
YANG M, Tang Y, Zhu P, Lu H, et al The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia.
Ann Hematol. 2024;103:3385-3398. PubMedAbstract available
WEI Z, Su L, Gao S The roles of ubiquitination in AML.
Ann Hematol. 2024;103:3413-3428. PubMedAbstract available
August 2024
XU Q, Li H, Huang P, Lin W, et al Investigation of infections status in pediatric patients with acute myeloid
leukemia during the induction period-a retrospective study in two medical
centers.
Ann Hematol. 2024 Aug 31. doi: 10.1007/s00277-024-05939. PubMedAbstract available
JIMENEZ-VICENTE C, Guardia-Torrelles A, Perez-Valencia AI, Martinez-Roca A, et al Clinical management of patients diagnosed with acute myeloid leukemia treated
with venetoclax in combination with hypomethylating agents after achieving a
response: a real-life study.
Ann Hematol. 2024 Aug 29. doi: 10.1007/s00277-024-05923. PubMedAbstract available
KLOS C, Roynard P, Berthon C, Soenen V, et al Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid
leukemia using Optical Genome Mapping.
Ann Hematol. 2024 Aug 29. doi: 10.1007/s00277-024-05948. PubMed
PRAJAPATI SK, Kumari N, Bhowmik D, Gupta R, et al Recent advancements in biomarkers, therapeutics, and associated challenges in
acute myeloid leukemia.
Ann Hematol. 2024 Aug 29. doi: 10.1007/s00277-024-05963. PubMedAbstract available
SOLIS-ARMENTA R, Rodriguez-Rodriguez S, Hernandez-Perez AP, Paulina-Zapata N, et al Understanding factors limiting hematopoietic cell transplantation for acute
myeloid leukemia patients in Mexico: a comprehensive analysis.
Ann Hematol. 2024 Aug 23. doi: 10.1007/s00277-024-05956. PubMedAbstract available
BADER MS, Kubetzko S, Schafer BW, Arranto C, et al Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts
post-transplant relapse and survival in adult patients with acute lymphoblastic
leukemia.
Ann Hematol. 2024 Aug 21. doi: 10.1007/s00277-024-05943. PubMed
MENG Z, Zheng H, Liu Y, Guo X, et al Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a
meta-analysis and systematic review.
Ann Hematol. 2024 Aug 21. doi: 10.1007/s00277-024-05667. PubMedAbstract available
YANG Y, Wang L, Peng Y, Nie X, et al Analysis of the occurrence and liver function characteristics of
arsenic-associated liver injury during the treatment of pediatric patients with
acute promyelocytic leukemia.
Ann Hematol. 2024 Aug 21. doi: 10.1007/s00277-024-05954. PubMedAbstract available
SUGITA J, Morita K, Konuma T, Yanada M, et al Allogeneic hematopoietic cell transplantation from alternative donors in acute
myeloid leukemia.
Ann Hematol. 2024 Aug 17. doi: 10.1007/s00277-024-05944. PubMedAbstract available
NUNES RAB, Avezum A, de Oliveira Marques M, Baiocchi OCCG, et al Three-year cardiovascular and non-cardiovascular adverse events in patients with
chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with
Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world
analysis.
Ann Hematol. 2024 Aug 17. doi: 10.1007/s00277-024-05921. PubMedAbstract available
TARANTINI F, Cumbo C, Parciante E, Anelli L, et al IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall
of myelodysplastic/myeloproliferative neoplasms.
Ann Hematol. 2024 Aug 15. doi: 10.1007/s00277-024-05938. PubMed
YAO Y, Zhou J, Li Y, Shi S, et al CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic
leukemia.
Ann Hematol. 2024 Aug 15. doi: 10.1007/s00277-024-05945. PubMed
SU Z, Cong B, Dong P A novel FNDC3B::MECOM fusion gene accompanied with Der(5; 17)(p10; q10) in acute
myelocytic leukemia.
Ann Hematol. 2024 Aug 14. doi: 10.1007/s00277-024-05930. PubMed
LAU C, van Kesteren C, Cao YX, Smeenk RM, et al Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia
patients following bariatric surgery: a case series.
Ann Hematol. 2024 Aug 12. doi: 10.1007/s00277-024-05924. PubMedAbstract available
FORGHIERI F, Cordella S, Marchesi F, Itri F, et al Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster
virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia:
results of a survey submitted to Italian centers belonging to SEIFEM
(Sorveglianza Epidemi
Ann Hematol. 2024 Aug 8. doi: 10.1007/s00277-024-05927. PubMed
WANG SX, Wang F, Tu YC, Zhou YL, et al Rare case of simultaneous occurrence of chronic neutrophil leukemia and T
lymphoblastic lymphoma: case report and literature review.
Ann Hematol. 2024 Aug 6. doi: 10.1007/s00277-024-05759. PubMedAbstract available
TAMELLINI E, Simio C, Bernardelli A, Ferrarini I, et al Successful rechallenge with azacytidine and venetoclax after sustained
treatment-free remission in a relapsed acute myeloid leukemia patient: a case
report.
Ann Hematol. 2024 Aug 3. doi: 10.1007/s00277-024-05922. PubMedAbstract available
GUO W, Zhang H, Wang M, Zheng Y, et al WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome
with excess blasts 2 patients.
Ann Hematol. 2024;103:2827-2836. PubMedAbstract available
CHOQUET S, Marchal C, Deygas F, Deslandes M, et al A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia
in a real-life setting in France using the national claims database (OSIRIS).
Ann Hematol. 2024;103:2969-2981. PubMedAbstract available
GUO W, Zhang H, Zheng Y, Gao H, et al Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk
AML after Allo-HSCT.
Ann Hematol. 2024;103:3155-3163. PubMedAbstract available
SUAREZ EU, Boluda B, Lavilla E, Tormo M, et al Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with
non-intensive regimens?
Ann Hematol. 2024;103:2845-2851. PubMedAbstract available
SHI H, Yang F, Cao M, Xu T, et al Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients:
Single-arm, open-label, phase I study.
Ann Hematol. 2024;103:2993-3004. PubMedAbstract available
KT MF, Semwal M, Yoosuf BT, Lad D, et al Venetoclax adverse event monitoring: a safety meta-analysis of randomized
controlled trials and a retrospective evaluation of the FAERS.
Ann Hematol. 2024;103:3179-3191. PubMedAbstract available
HU R, Liao P, Xu B, Qiu Y, et al N6-methyladenosine RNA modifications: a potential therapeutic target for AML.
Ann Hematol. 2024;103:2601-2612. PubMedAbstract available
July 2024
DENG J, Qin X, Ma G, Shen X, et al Development of a clinical prognostic model for primary plasma cell leukemia
patients treated with novel agents: a multicenter retrospective cohort study.
Ann Hematol. 2024 Jul 29. doi: 10.1007/s00277-024-05862. PubMedAbstract available
FAN BE, Chow M Artificial intelligence assisted diagnosis of chronic lymphocytic leukemia in a
historic pediatric case using large language models.
Ann Hematol. 2024 Jul 29. doi: 10.1007/s00277-024-05916. PubMed
ROBAK T, Pula A, Braun M, Robak E, et al Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an
update.
Ann Hematol. 2024 Jul 25. doi: 10.1007/s00277-024-05854. PubMedAbstract available
DAI Y, Luo L, Wei Z, Cheng P, et al The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute
leukemia: a single-center experience.
Ann Hematol. 2024 Jul 24. doi: 10.1007/s00277-024-05892. PubMedAbstract available
LIPTON JH, Brummendorf TH, Sweet K, Apperley JF, et al Practical considerations in the management of patients treated with bosutinib for
chronic myeloid leukemia.
Ann Hematol. 2024 Jul 18. doi: 10.1007/s00277-024-05851. PubMedAbstract available
ZHAO Y, Huang Y, Jiang L, Zhang Y, et al Impact of different CEBPA mutations on therapeutic outcome in acute myeloid
leukemia.
Ann Hematol. 2024 Jul 18. doi: 10.1007/s00277-024-05884. PubMedAbstract available
KONTANDREOPOULOU CN, Solomou EE, Kolorizos E, Diamantopoulos PT, et al Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2
immunization for patients with chronic lymphocytic leukemia.
Ann Hematol. 2024 Jul 15. doi: 10.1007/s00277-024-05869. PubMedAbstract available
CAO HY, Li HY, Cai WZ, Huang YH, et al Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with
MEF2D fusions and report of two novel MEF2D rearrangements.
Ann Hematol. 2024 Jul 11. doi: 10.1007/s00277-024-05868. PubMedAbstract available
BUDAK B, Tukel EY, Turanli B, Kiraz Y, et al Correction to: Integrated systems biology analysis of acute lymphoblastic
leukemia: unveiling molecular signatures and drug repurposing opportunities.
Ann Hematol. 2024 Jul 11. doi: 10.1007/s00277-024-05881. PubMed
LAIMON DN, Sakr DH, Atef B, Shaaban Y, et al Highlights of ophthalmological manifestations in newly diagnosed acute leukemia:
a correlation with hematological parameters.
Ann Hematol. 2024 Jul 10. doi: 10.1007/s00277-024-05861. PubMedAbstract available
SINGH S, Lionel S, Jain H, Rajendra A, et al Treatment challenges and outcomes of older patients with acute myeloid leukemia
from India.
Ann Hematol. 2024 Jul 8. doi: 10.1007/s00277-024-05873. PubMedAbstract available
ZHENG J, Zhao Y, Luo Y, Yu J, et al Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults
patients with Philadelphia chromosome positive acute lymphoblastic leukemia
undergoing allogeneic hematopoietic cell transplantation: a retrospective
analysis.
Ann Hematol. 2024 Jul 4. doi: 10.1007/s00277-024-05871. PubMedAbstract available
WANG J, Mu M, Zhu J, Yang J, et al Adult acute leukemia patients with gram-negative bacteria bloodstream infection:
Risk factors and outcomes of antibiotic-resistant bacteria.
Ann Hematol. 2024 Jul 3. doi: 10.1007/s00277-024-05866. PubMedAbstract available
CHEN R, Tao Q, Wu F, Zhai Z, et al DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with
relapsed and refractory B-ALL.
Ann Hematol. 2024;103:2551-2556. PubMedAbstract available
PANDA D, Tejwani N, Pandey P, Mehta A, et al Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse;
no longer a pediatric disease.
Ann Hematol. 2024;103:2561-2563. PubMed
CHEN Y, Chen Y, Wu Z, Li J, et al Nomogram predictive models for adult patients with acute lymphoblastic leukaemia
based on real-world treatment outcomes.
Ann Hematol. 2024;103:2393-2404. PubMedAbstract available
June 2024
GONG Y, Li Y, Chen X, Yang H, et al Refractory pure red cell aplasia associated with T-cell large granular lymphocyte
leukemia treated by ruxolitinib.
Ann Hematol. 2024 Jun 27. doi: 10.1007/s00277-024-05856. PubMedAbstract available
SHI Y, Chen X, Jin H, Zhu L, et al Correction to: Clinical prognostic value of different NPM1 mutations in acute
myeloid leukemia patients.
Ann Hematol. 2024 Jun 24. doi: 10.1007/s00277-024-05812. PubMed
CAO X, Li Z, Zhang Y, Cui Q, et al Chidamide combined with a modified Bu-Cy conditioning regimen improves survival
in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing
allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2024 Jun 20. doi: 10.1007/s00277-024-05849. PubMedAbstract available
ZHOU K, Wang T, Pan L, Xu W, et al Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with
relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup
of ALPINE.
Ann Hematol. 2024 Jun 18. doi: 10.1007/s00277-024-05823. PubMedAbstract available
WANG XZ, Gao XM, Wang JM, Cai H, et al Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid
leukemia with FLT3-ITD and PTPN11 mutations.
Ann Hematol. 2024 Jun 15. doi: 10.1007/s00277-024-05842. PubMedAbstract available
ABULIMITI M, Jia ZY, Wu Y, Yu J, et al Exploring and clinical validation of prognostic significance and therapeutic
implications of copper homeostasis-related gene dysregulation in acute myeloid
leukemia.
Ann Hematol. 2024 Jun 15. doi: 10.1007/s00277-024-05841. PubMedAbstract available
LI T, Wu P, Wang A, Chen M, et al A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid
sarcoma of the spine.
Ann Hematol. 2024 Jun 12. doi: 10.1007/s00277-024-05833. PubMed
ZHANG Z, Fu C, Sun Y, Liu Y, et al High hyperdiploid karyotype with >/= 49 chromosomes represents a heterogeneous
subgroup of acute myeloid leukemia with differential TP53 mutation status and
prognosis: a single-center study from China.
Ann Hematol. 2024 Jun 8. doi: 10.1007/s00277-024-05834. PubMedAbstract available
WEI D, Liang X, Huang M, Wang C, et al Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers
imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia.
Ann Hematol. 2024 Jun 7. doi: 10.1007/s00277-024-05830. PubMedAbstract available
BOUCHLA A, Sotiropoulou CD, Esteb C, Loupis T, et al Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid
leukemia cells to chemotherapy.
Ann Hematol. 2024 Jun 6. doi: 10.1007/s00277-024-05785. PubMedAbstract available
BUDAK B, Tukel EY, Turanli B, Kiraz Y, et al Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling
molecular signatures and drug repurposing opportunities.
Ann Hematol. 2024 Jun 5. doi: 10.1007/s00277-024-05821. PubMedAbstract available
ZHENG B, Geng Y, Li Y, Huang H, et al Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell
proliferation and apoptosis through beta-catenin by acting as targets of miR-495-3p.
Ann Hematol. 2024 Jun 3. doi: 10.1007/s00277-024-05764. PubMedAbstract available
JAIN AG, Gesiotto Q, Ball S, Nodzon L, et al Incidence of pleural effusion with dasatinib and the effect of switching therapy
to a different TKI in patients with chronic phase CML.
Ann Hematol. 2024;103:1941-1945. PubMedAbstract available
May 2024
LI Y, Zhang Q, Shao H Chemotherapy vs. "TKI + immunotherapy" in treatment of B-cell acute lymphoblastic
leukemia harboring the RCSD1::ABL2 fusion gene.
Ann Hematol. 2024 May 29. doi: 10.1007/s00277-024-05816. PubMed
WANG Q, Hu Y, Gao L, Zhang S, et al Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with
avapritinib post-stem cell transplantation: a report of four cases.
Ann Hematol. 2024 May 28. doi: 10.1007/s00277-024-05810. PubMedAbstract available
BRAUN A, Otoukesh S, Tinajero J, Marcucci G, et al Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell
acute lymphoblastic leukemia (B-ALL).
Ann Hematol. 2024 May 24. doi: 10.1007/s00277-024-05795. PubMedAbstract available
IOVENE FR, Santinelli E, Armiento D, Sarlo C, et al Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a
personalized antileukemic and immunosuppressive strategy.
Ann Hematol. 2024 May 23. doi: 10.1007/s00277-024-05804. PubMedAbstract available
CUI T, Li H, Zhou S, Li J, et al Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to
allogeneic hematopoietic stem cell transplantation in relapsed or refractory
acute myeloid leukemia.
Ann Hematol. 2024 May 17. doi: 10.1007/s00277-024-05791. PubMedAbstract available
FONTECHA MB, Anadon MDR, Mercado Guzman V, Stanganelli C, et al Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic
leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.
Ann Hematol. 2024 May 14. doi: 10.1007/s00277-024-05794. PubMedAbstract available
TOLLE M, Gokbuget N, Habringer S, Keller U, et al Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a
patient with acute lymphoblastic leukemia.
Ann Hematol. 2024 May 11. doi: 10.1007/s00277-024-05789. PubMed
SHI Y, Chen X, Jin H, Zhu L, et al Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia
patients.
Ann Hematol. 2024 May 9. doi: 10.1007/s00277-024-05786. PubMedAbstract available
MITROVIC-AJTIC O, Zivkovic E, Suboticki T, Diklic M, et al Inflammation mediated angiogenesis in chronic lymphocytic leukemia.
Ann Hematol. 2024 May 7. doi: 10.1007/s00277-024-05781. PubMedAbstract available
MENSHAWY NE, El-Ghonemy MS, Ebrahim MA, Fahmi MW, et al Aberrant ecotropic viral integration site-1 (EVI-1) and myocyte enhancer factor
2 C gene (MEF2C) in adult acute myeloid leukemia are associated with adverse t
(9:22) & 11q23 rearrangements.
Ann Hematol. 2024 May 7. doi: 10.1007/s00277-024-05779. PubMedAbstract available
FRANKE GN, Loewe G, Reiser M, Linde H, et al Spotlight on the real-world treatment of CML pts in Germany: a retrospective
survey in private oncology practices.
Ann Hematol. 2024;103:1569-1575. PubMedAbstract available
NISCOLA P, Gianfelici V, Giovannini M, Piccioni D, et al Very long-term efficacy of venetoclax combined with hypomethylating agents in two
AML elderly: is it the time for treatment discontinuation strategies?
Ann Hematol. 2024;103:1787-1788. PubMed
SHUMILOV E, Mazzeo P, Ghandili S, Kunstner A, et al Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in
close interaction with therapeutic considerations.
Ann Hematol. 2024;103:1587-1599. PubMedAbstract available
April 2024
LIU Y, Liu Y, Chen P, Chen G, et al GLI1 polymorphisms influence remission rate and prognosis of young de novo acute
myeloid leukemia patients treated with cytarabine-based chemotherapy.
Ann Hematol. 2024 Apr 27. doi: 10.1007/s00277-024-05777. PubMedAbstract available
TAZOE K, Harada N, Makuuchi Y, Kuno M, et al Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem
cell transplantation is a risk factor for death in patients with myelodysplastic
syndrome or chronic myelomonocytic leukemia.
Ann Hematol. 2024 Apr 25. doi: 10.1007/s00277-024-05772. PubMedAbstract available
BENCHIKH S, Charlene SSG, Bousfiha A, Razoki L, et al Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco.
Ann Hematol. 2024 Apr 24. doi: 10.1007/s00277-024-05747. PubMedAbstract available
THAU S, Poulsen CB, Brieghel C, Larsen MK, et al COVID-19 severity in patients with chronic lymphocytic leukemia treated with
venetoclax: a single-center observational cohort study.
Ann Hematol. 2024 Apr 18. doi: 10.1007/s00277-024-05738. PubMedAbstract available
JEBANESAN DZP, Illangeswaran RSS, Rajamani BM, Vidhyadharan RT, et al Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in
FLT3-mutated Acute Myeloid Leukemia.
Ann Hematol. 2024 Apr 17. doi: 10.1007/s00277-024-05742. PubMedAbstract available
LEOTTA S, Markovic U, Duminuco A, Mule A, et al Impact of minimal residual disease response and of status of disease on survival
after blinatumomab in B-cell acute lymphoblastic leukemia: results from a
real-life study.
Ann Hematol. 2024 Apr 13. doi: 10.1007/s00277-024-05725. PubMedAbstract available
GU Z, Li F, Li M, Wang L, et al Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute
lymphoblastic leukemia/lymphoma in first complete remission: a single-center
study.
Ann Hematol. 2024 Apr 12. doi: 10.1007/s00277-024-05716. PubMedAbstract available
LUO L, Jiao Y, Li Y, Yang P, et al Efficacy and prognostic factors of allogeneic hematopoietic stem cell
transplantation treatment for adolescent and adult Tlymphoblastic leukemia
/lymphoma: a large cohort multicenter study in China.
Ann Hematol. 2024 Apr 6. doi: 10.1007/s00277-024-05719. PubMedAbstract available
PEREZ-LAMAS L, de Paz Arias R, Diaz RMA, Montero LFC, et al Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and
atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC
study.
Ann Hematol. 2024 Apr 3. doi: 10.1007/s00277-024-05662. PubMedAbstract available
LIU S, Cui Q, Li M, Li Z, et al Successful treatment of a B/T MPAL patient by chemo-free treatment with
venetoclax, azacitidine, and blinatumomab.
Ann Hematol. 2024;103:1397-1402. PubMedAbstract available
REN Y, Liu F, Chen X, Zhang X, et al Decitabine-containing conditioning improved outcomes for children with
higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem
cell transplantation.
Ann Hematol. 2024;103:1345-1351. PubMedAbstract available
LUCERO J, Alhumaid M, Novitzky-Basso I, Capo-Chichi JM, et al Flow cytometry-based measurable residual disease (MRD) analysis identifies AML
patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2024;103:1187-1196. PubMedAbstract available
WANG J, Zhu H, Miao K Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid
leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem
cell transplantation: a case report.
Ann Hematol. 2024 Apr 1. doi: 10.1007/s00277-024-05714. PubMedAbstract available
March 2024
CHEN Y, Pan M, Chen L, Peng M, et al Correction to: Identification of a novel fusion gene, RARA::ANKRD34C, in acute
promyelocytic leukemia.
Ann Hematol. 2024 Mar 27. doi: 10.1007/s00277-024-05675. PubMed
WU CY, Yeh CM, Tsai CK, Liu CJ, et al The influence of hospital volume and physician volume on early mortality in acute
promyelocytic leukemia patients.
Ann Hematol. 2024 Mar 26. doi: 10.1007/s00277-024-05616. PubMedAbstract available
CAI X, Liu Y, Li H, Que Y, et al XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute
myeloid leukemia via downregulating glutathione pathway.
Ann Hematol. 2024 Mar 23. doi: 10.1007/s00277-024-05706. PubMedAbstract available
KUROSAWA S, Yokota T, Takada Y, Okubo S, et al Effective treatment of pleural effusion in chronic lymphocytic leukemia with
acalabrutinib: a case report.
Ann Hematol. 2024 Mar 21. doi: 10.1007/s00277-024-05721. PubMed
HUANG XT, Wang CJ, Gao C, Xue TL, et al Relationship between subtype-specific minimal residual disease level and
long-term prognosis in children with acute lymphoblastic leukemia.
Ann Hematol. 2024 Mar 18. doi: 10.1007/s00277-024-05687. PubMedAbstract available
OU J, Deng S, Ding C, Cai Z, et al Mutations of epigenetic modifier genes predict poor outcome in adult acute
lymphoblastic leukemia.
Ann Hematol. 2024 Mar 7. doi: 10.1007/s00277-024-05681. PubMedAbstract available
RORVIK SD, Torkildsen S, Bruserud O, Tvedt THA, et al Acute myeloid leukemia with rare recurring translocations-an overview of the
entities included in the international consensus classification.
Ann Hematol. 2024 Mar 6. doi: 10.1007/s00277-024-05680. PubMedAbstract available
DARTIGEAS C, Quinquenel A, Ysebaert L, Dilhuydy MS, et al Final results on effectiveness and safety of Ibrutinib in patients with chronic
lymphocytic leukemia from the non-interventional FIRE study.
Ann Hematol. 2024 Mar 6. doi: 10.1007/s00277-024-05666. PubMedAbstract available
WU X, Ma X, Song T, Liu J, et al The indirect effects of CMV reactivation on patients following allogeneic
hematopoietic stem cell transplantation: an evidence mapping.
Ann Hematol. 2024;103:917-933. PubMedAbstract available
KENNEDY A, Patel S, Ramanathan M, Gerber J, et al Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and
infection risk at a single center.
Ann Hematol. 2024;103:1031-1033. PubMed
KRECAK I, Cubric E, Smolic J, Vrbicic B, et al Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking
inflammatory bowel disease, successfully treated with acalabrutinib.
Ann Hematol. 2024;103:1021-1023. PubMed
PALANI HK, Ganesan S, Balasundaram N, Venkatraman A, et al Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia.
Ann Hematol. 2024 Mar 1. doi: 10.1007/s00277-024-05673. PubMed
February 2024
SCHWANER I, Kuhn T, Losem C, Wolff T, et al Low incidence of tumor lysis syndrome in elderly patients with chronic
lymphocytic leukemia treated with venetoclax under real-world conditions: results
from the prospective observational VeRVe study.
Ann Hematol. 2024 Feb 29. doi: 10.1007/s00277-024-05638. PubMedAbstract available
CHEN Y, Zheng J, Weng Y, Wu Z, et al Myelodysplasia-related gene mutations are associated with favorable prognosis in
patients with TP53-mutant acute myeloid leukemia.
Ann Hematol. 2024 Feb 27. doi: 10.1007/s00277-024-05679. PubMedAbstract available
TERAMOTO M, Tamaki H, Kaida K, Samori M, et al Pretransplantation predictors of survival in nonremission acute myeloid leukemia
treated with haploidentical transplantation using steroid-based GVHD prophylaxis.
Ann Hematol. 2024 Feb 23. doi: 10.1007/s00277-024-05654. PubMedAbstract available
WANG X, Zhang Y, Xue S Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia.
Ann Hematol. 2024 Feb 21. doi: 10.1007/s00277-023-05601. PubMedAbstract available
GOTO T, Nakamura N, Suzaki T, Shimazu R, et al A case of acute promyelocytic leukemia with pericardial effusion successfully
managed with colchicine during ATO administration.
Ann Hematol. 2024 Feb 20. doi: 10.1007/s00277-024-05660. PubMed
LI X, Zhou J, Li J, Zhu X, et al Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic
leukemia with Loeffler's endocarditis.
Ann Hematol. 2024 Feb 17. doi: 10.1007/s00277-024-05656. PubMed
ZHAO L, Yang J, Chen M, Xiang X, et al Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor
outcomes with venetoclax-based treatment: a monocentric real-world study.
Ann Hematol. 2024 Feb 8. doi: 10.1007/s00277-024-05646. PubMedAbstract available
FONTANA D, Zambrotta GPM, Scannella A, Piazza R, et al Late relapse of chronic myeloid leukemia after allogeneic bone marrow
transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with
insights on the molecular landscape.
Ann Hematol. 2024 Feb 7. doi: 10.1007/s00277-024-05649. PubMedAbstract available
SCHLOSSER P, Schiwitza A, Klaus J, Hieke-Schulz S, et al Conditional survival to assess prognosis in patients with chronic lymphocytic
leukemia.
Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05627. PubMedAbstract available
SUAREZ EU, Piris MA, Rodriguez-Pinilla SM, Garcia JF, et al Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute
leukemia of ambiguous lineage.
Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05647. PubMed
WANG J, Zhang H, Zhang R BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case
report.
Ann Hematol. 2024;103:685-687. PubMed
BRUNNER A, Thalhammer-Thurner GC, Willenbacher W, Haun M, et al In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation
may provide more precise diagnosis and rational treatment allocation.
Ann Hematol. 2024;103:553-563. PubMedAbstract available
FERNANDEZ-LUIS S, Gomez Lamas D, Cerezo Martin JM, Mora Barrios JM, et al Feasibility of allogeneic hematopoietic stem cell transplantation in advanced
age.
Ann Hematol. 2024;103:583-591. PubMedAbstract available
January 2024
CHEN Y, Pan M, Chen L, Peng M, et al Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic
leukemia.
Ann Hematol. 2024 Jan 31. doi: 10.1007/s00277-024-05629. PubMedAbstract available
CUI J, Zhao M, Liu W, Hong M, et al Effect of low skeletal muscle mass on NK cells in patients with acute myeloid
leukemia and its correlation with prognosis.
Ann Hematol. 2024 Jan 31. doi: 10.1007/s00277-024-05645. PubMedAbstract available
LIU Y, Ma Z Leukemia and mitophagy: a novel perspective for understanding oncogenesis and
resistance.
Ann Hematol. 2024 Jan 29. doi: 10.1007/s00277-024-05635. PubMedAbstract available
GABELLIER L, Peterlin P, Thepot S, Hicheri Y, et al Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia:
a French multicentric retrospective study.
Ann Hematol. 2024 Jan 26. doi: 10.1007/s00277-024-05623. PubMedAbstract available
CHATTOPADHYAY S, Lionel S, Selvarajan S, Devasia AJ, et al Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia
following immunosuppressive therapy for aplastic anemia is more common as
compared to allogeneic stem cell transplantation with a negative impact on
survival.
Ann Hematol. 2024 Jan 20. doi: 10.1007/s00277-024-05621. PubMedAbstract available
MURRU R, Galitzia A, Barabino L, Presicci R, et al Prediction of severe infections in chronic lymphocytic leukemia: a simple risk
score to stratify patients at diagnosis.
Ann Hematol. 2024 Jan 18. doi: 10.1007/s00277-024-05625. PubMedAbstract available
ZHAO Y, Zhang X, Zhang M, Guo R, et al Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid
leukemia following CLL1 CAR-T cell therapy.
Ann Hematol. 2024 Jan 12. doi: 10.1007/s00277-024-05617. PubMedAbstract available
DEREME J, Voruz S, Solly F, Schoumans J, et al Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24
years after treatment-free remission for chronic myeloid leukemia with identical
BCR-ABL fusion transcript.
Ann Hematol. 2024 Jan 9. doi: 10.1007/s00277-023-05600. PubMed
SONG J, Li W, Bai Y, Zhou P, et al A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively
associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute
myeloid leukemia.
Ann Hematol. 2024 Jan 6. doi: 10.1007/s00277-023-05594. PubMedAbstract available
PERRUSO LL, Velloso E, Rocha V, Rego EM, et al Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed
acute lymphoblastic leukemia.
Ann Hematol. 2024 Jan 5. doi: 10.1007/s00277-023-05609. PubMedAbstract available
WANG R, Xu Y, Wang B, Wang H, et al Hypomethylating agents (HMAs) show benefit in AML rather than in
intermediate/high-risk MDS based on genetic mutations in epigenetic modification
(EMMs): from a retrospective study.
Ann Hematol. 2024;103:61-71. PubMedAbstract available
AL BARASHDI MAS, Ali A, McMullin MF, Mills K, et al CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to
chemotherapy.
Ann Hematol. 2024;103:73-88. PubMedAbstract available
December 2023
HUANG P, Chang H, Zhang R, Wu Y, et al Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with
acute leukemia.
Ann Hematol. 2023 Dec 28. doi: 10.1007/s00277-023-05593. PubMedAbstract available
PAN B, Xu Z, Du K, Gao R, et al Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide
clinical outcome and therapy.
Ann Hematol. 2023 Dec 27. doi: 10.1007/s00277-023-05590. PubMedAbstract available
SOBAS M, Knopinska-Posluszny W, Piatkowska-Jakubas B, Garcia-Alvarez F, et al Incidence, risk factors, and outcomes of second neoplasms in patients with acute
promyelocytic leukemia: the PETHEMA-PALG experience.
Ann Hematol. 2023 Dec 19. doi: 10.1007/s00277-023-05582. PubMedAbstract available
PARK T, Byun JM, Shin DY, Koh Y, et al Clinical characteristics and treatment outcomes of Asian patients with T-cell
large granular lymphocytic Leukemia: a single-center analysis of 67 cases.
Ann Hematol. 2023 Dec 8. doi: 10.1007/s00277-023-05575. PubMedAbstract available
ZHENG X, Gao H, Lu N, Wang M, et al Efficacy of venetoclax combined with decitabine conditioning regimen for
allogeneic hematopoietic stem cell transplantation in high-risk and elderly
patients with myeloid neoplasms.
Ann Hematol. 2023;102:3603-3611. PubMedAbstract available
HU J, Zhao J, Wang C, Jia M, et al Epstein-Barr virus reactivation correlates with worse outcomes for patients
exposed to hepatitis B virus after haploidentical hematopoietic stem cell
transplantation.
Ann Hematol. 2023;102:3593-3601. PubMedAbstract available
ANDERSEN M JR, Bindal P, Michaels P, Elavalakanar P, et al Clonal myeloid disorders following CAR T-cell therapy.
Ann Hematol. 2023;102:3643-3645. PubMed
BEWERSDORF JP, Shallis RM, Sharon E, Park S, et al A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in
combination with pembrolizumab in patients with myelodysplastic
syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating
agents.
Ann Hematol. 2023 Dec 1. doi: 10.1007/s00277-023-05552. PubMedAbstract available
November 2023
MARRA JD, Frioni F, Minnella G, Rossi M, et al Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in
classification and management.
Ann Hematol. 2023 Nov 29. doi: 10.1007/s00277-023-05561. PubMed
MULAS O, Abruzzese E, Luciano L, Iurlo A, et al The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the
risk of arterial occlusive events in chronic myeloid leukemia patients treated
with nilotinib or ponatinib.
Ann Hematol. 2023 Nov 28. doi: 10.1007/s00277-023-05556. PubMedAbstract available
ISHIDA H, Arakawa Y, Hasegawa D, Usami I, et al Reduced-intensity allogenic transplantation for children and adolescents with
Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ann Hematol. 2023 Nov 25. doi: 10.1007/s00277-023-05557. PubMedAbstract available
FISCHER D, Toenges R, Kiil K, Michalik S, et al Liver failure after treatment with inotuzumab and polychemotherapy including
PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative
acute lymphoblastic leukemia.
Ann Hematol. 2023 Nov 24. doi: 10.1007/s00277-023-05495. PubMedAbstract available
SHANG CY, Bei LY, Wu JZ, Sheng HR, et al NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic
lymphocytic leukemia.
Ann Hematol. 2023 Nov 23. doi: 10.1007/s00277-023-05554. PubMedAbstract available
GAO J, Han S, Deng B, Deng Y, et al Research progress of additional pathogenic mutations in chronic neutrophilic
leukemia.
Ann Hematol. 2023 Nov 22. doi: 10.1007/s00277-023-05550. PubMedAbstract available
TIAN J, Wei A, Wang B, Yang J, et al Allogeneic hematopoietic stem cell transplantation for pediatric acute
lymphoblastic leukemia.
Ann Hematol. 2023 Nov 22. doi: 10.1007/s00277-023-05506. PubMedAbstract available
LAP CJ, Abrahim MS, Nassereddine S Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated
acute myeloid leukemia.
Ann Hematol. 2023 Nov 17. doi: 10.1007/s00277-023-05545. PubMedAbstract available
CHEN B, Zhao Y, Xu S, Jiang F, et al USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by
inhibiting STUB1-induced NFAT5 ubiquitination.
Ann Hematol. 2023 Nov 10. doi: 10.1007/s00277-023-05522. PubMedAbstract available
LUCIJANIC M, Tomasovic-Loncaric C, Stoos-Veic T, De Both T, et al Myeloid sarcoma of the urinary bladder as the presenting feature of secondary
acute myeloid leukemia, successfully treated with venetoclax and azacitidine.
Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05529. PubMed
AHMED HA, Nafady A, Ahmed EH, Hassan EEN, et al CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide
prediction of disease activity and progression-free survival in chronic
lymphocytic leukemia.
Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05540. PubMedAbstract available
FAN S, Wang L, Lu Y, Li Z, et al Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia
chromosome-positive acute lymphoblastic leukemia: two-case report.
Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05519. PubMedAbstract available
DE OLIVEIRA FERNANDES JUNIOR I, Arcuri LJ Myeloablative or reduced-intensity/non-myeloablative hematopoietic cell
transplantation for Philadelphia-positive acute lymphoblastic leukemia in adults
older than 40 years old - a secondary analysis of a CIBMTR database.
Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05532. PubMedAbstract available
BABAKHANLOU R, Nader ME, Alvarado Y Correction to: A case of sudden hearing loss in a patient with chronic
myelomonocytic leukemia.
Ann Hematol. 2023 Nov 3. doi: 10.1007/s00277-023-05524. PubMed
HUSSAN SS, Ali MS, Fatima M, Altaf M, et al Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a
subtype classifier for acute lymphoblastic leukemia.
Ann Hematol. 2023 Nov 3. doi: 10.1007/s00277-023-05515. PubMedAbstract available
HUANG X, Li T, Zhang Y, Gao X, et al Hemophagocytosis by multinucleated leukemic blasts, basophilia, and
micromegakaryocytes in AML with TLS::ERG.
Ann Hematol. 2023;102:3279-3281. PubMed
PERRONE S, Imperatore S, Sucato G, Notarianni E, et al Gilteritinib and the risk of intracranial hemorrhage: a case series of a
possible, under-reported side effect.
Ann Hematol. 2023;102:3025-3030. PubMedAbstract available
HEGDE NC, Kumar A, Kaundal S, Saha L, et al Generic ibrutinib a potential cost-effective strategy for the first-line
treatment of chronic lymphocytic leukaemia.
Ann Hematol. 2023;102:3125-3132. PubMedAbstract available
October 2023
SAVANI S, Chennapragada SS, Ramphul K, Dandwani M, et al Factors associated with inpatient mortality during daunorubicin and cytarabine
induction in adults with acute myeloid leukemia-a national inpatient sample
analysis.
Ann Hematol. 2023 Oct 27. doi: 10.1007/s00277-023-05505. PubMed
TANG H, Chen Y, Zhang N, Deng J, et al Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is
associated with better prognosis after chemotherapy.
Ann Hematol. 2023 Oct 25. doi: 10.1007/s00277-023-05516. PubMedAbstract available
CUI Y, Peng H Imatinib and CAR T cell therapy enable sustained response in a young patient with
refractory RCSD1-ABL1-positive acute lymphoblastic leukemia.
Ann Hematol. 2023 Oct 21. doi: 10.1007/s00277-023-05489. PubMed
FEI X, Zhang W, Gu J, Yang F, et al CLAG combined with total body irradiation as intensive conditioning chemotherapy
prior to allogeneic hematopoietic stem cell transplantation in patients with
refractory or relapsed acute myeloid leukemia.
Ann Hematol. 2023 Oct 17. doi: 10.1007/s00277-023-05502. PubMedAbstract available
YIN S, Zheng X, Zhang W, Zhao H, et al Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in
chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and
meta-analysis.
Ann Hematol. 2023 Oct 16. doi: 10.1007/s00277-023-05486. PubMedAbstract available
EISENACH S, Zinke J, Bramer D, Hartinger S, et al Detection of a rare JAK2(exon13InDel)-mutation in chronic eosinophilic leukemia
with bilateral cerebral infarctions and Loffler endocarditis.
Ann Hematol. 2023 Oct 16. doi: 10.1007/s00277-023-05490. PubMed
CREMER A, Enssle JC, Pfaff S, Kouidri K, et al Treatment with midostaurin and other FLT3 targeting inhibitors is associated with
an increased risk of cardiovascular adverse events in patients who underwent
allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.
Ann Hematol. 2023;102:2903-2908. PubMedAbstract available
MARTINO G, Cimino G, Caridi M, Perta G, et al One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Ann Hematol. 2023;102:2969-2971. PubMed
September 2023
XU Y, Gao H, Li H The gut microbiome: an important factor influencing therapy for pediatric acute
lymphoblastic leukemia.
Ann Hematol. 2023 Sep 29. doi: 10.1007/s00277-023-05480. PubMedAbstract available
PEREIRA MP, Herrity E, Kim DDH TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology,
treatment challenges, and upcoming approaches.
Ann Hematol. 2023 Sep 28. doi: 10.1007/s00277-023-05462. PubMedAbstract available
ZOU D, Lv M, Chen Y, Niu T, et al Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic
leukemia cells and increases sensitivity to dexamethasone.
Ann Hematol. 2023 Sep 26. doi: 10.1007/s00277-023-05468. PubMedAbstract available
CANDAN O, Demirtas D, Yanik AM, Atagunduz I, et al The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic
leukemia.
Ann Hematol. 2023 Sep 20. doi: 10.1007/s00277-023-05456. PubMed
LIN Q, Ye P, Wang T, Lu Y, et al Successful use of venetoclax combined with azacitidine in isolated extramedullary
relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell
transplantation: a case report.
Ann Hematol. 2023 Sep 20. doi: 10.1007/s00277-023-05401. PubMed
LI H, Hou J, Fu Y, Zhao Y, et al miR-603 promotes cell proliferation and differentiation by targeting TrkB in
acute promyelocytic leukemia.
Ann Hematol. 2023 Sep 19. doi: 10.1007/s00277-023-05441. PubMedAbstract available
WENG G, Huang J, He X, Xue T, et al Hypomethylating agents plus modified priming regimens compared with
venetoclax-based regimens based on molecular characteristics for newly diagnosed
patients with acute myeloid leukemia: a multi-center cohort study.
Ann Hematol. 2023 Sep 18. doi: 10.1007/s00277-023-05452. PubMedAbstract available
BABAKHANLOU R, Ellie-Nader M, Alvarado Y A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia.
Ann Hematol. 2023 Sep 15. doi: 10.1007/s00277-023-05433. PubMedAbstract available
CROUCHER PJP, Ridinger M, Becker PS, Lin TL, et al Spliceosome mutations are associated with clinical response in a phase 1b/2 study
of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or
refractory acute myeloid leukemia.
Ann Hematol. 2023 Sep 13. doi: 10.1007/s00277-023-05442. PubMedAbstract available
JIANG S, Lu X, Wei R, Zhang A, et al Salvage hematopoietic stem cell transplantation for patients with higher leukemia
burden in relapsed or refractory acute myeloid leukemia: a ten-year study.
Ann Hematol. 2023 Sep 8. doi: 10.1007/s00277-023-05406. PubMedAbstract available
WANG Q, Liang Z, Ren H, Dong Y, et al Real-world outcomes and prognostic factors among patients with acute myeloid
leukemia treated with allogeneic hematopoietic stem cell transplantation.
Ann Hematol. 2023 Sep 4. doi: 10.1007/s00277-023-05429. PubMedAbstract available
LIU Y, Chen P, Chen G, Chen X, et al E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in
patients with acute myeloid leukemia.
Ann Hematol. 2023 Sep 4. doi: 10.1007/s00277-023-05431. PubMedAbstract available